South San Francisco, CA · Founded 2021 · Privately Held (backing)
Developer of precision medicines designed for epigenetic reprogramming to restore youthful function in aging cells. NewLimit is based in South San Francisco, CA and was founded in 2021. It was valued at $1.6 billion at its early-stage round in Oct 2025, the last priced event on record. It has raised $247 million across 2 recorded rounds; the latest was a $130 million later-stage round in May 2025.
PMV mark · valuation
$1.6B
Oct 2026
Priced at
its early-stage round
Oct 2025
Total raised
$247.3M
Last round
Later Stage VC
May 2025
Team — not yet on record
No current team members for NewLimit are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of NewLimit with a free account
·The complete investor list: 24 names
·Watch NewLimit: the Monday email on marks, rounds and moves
